Most Recent
International airline Air New Zealand has been hit with a $15 million penalty for participating in a global air cargo cartel to fix the price of fuel, insurance and security surcharges.
Generic pharmaceutical company Aspen Pharma has resolved a patent infringement case brought by the maker of the anti-depressant Lexapro, according to a Federal Court order Tuesday.
A judge has granted F. Hoffman La-Roche's request for a temporary order blocking Sandoz from making or selling a biosimilar version of its patented biologic used to treat various cancers and rheumatoid arthritis.
A judge has ordered mediation in the Brisbane floods class action, in which the victims of the 2011 disaster are seeking up to $1 billion in compensation.
As the ACCC's criminal cartel case against ANZ, Citigroup and Deutsche Bank gets underway, the regulator will face off against a formidable team of lawyers with extensive experience in defending competition matters.
Three generic drug manufacturers cannot claim damages for an injunction barring the release of cheaper versions of Effexor-XR, even if the injunction was later overturned, pharmaceutical giant Wyeth told a judge on day two of a six-week trial over its blockbuster antidepressant.
Pharmaceutical giant Wyeth's has launched an "ambush" at the beginning of a trial after a nine-year long battle against several generic drug makers, alleging infringement of a second patent for its blockbuster Effexor-XR, a judge heard Monday.
A decade-long courtroom battle over a patent for Effexor-XR that delayed the release of cheap versions of the anti-depressant is at the centre of a trial starting Monday in Sydney pitting four generic drug makers against pharmaceutical giant Wyeth.
Telecommunications company Optus asked a judge Friday to award damages for customers it lost as a result of Telstra's "Unlimited" ad campaign, which the Federal Court ruled last week was misleading and deceptive.
A judge has lifted an injunction against an Optus ad campaign after ruling that Telstra failed to make its case that the 'Empires End' campaign was misleading or deceptive.